UTHR vs. META
UTHR (United Therapeutics Corporation) and META (Meta Platforms, Inc.) are both stocks. UTHR operates in Biotechnology (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 10 years, UTHR returned 17.67%/yr vs 17.39%/yr for META. At a 0.19 correlation, their price movements are largely independent.
Performance
UTHR vs. META - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTHR achieves a 12.05% return, which is significantly higher than META's -14.03% return. Both investments have delivered pretty close results over the past 10 years, with UTHR having a 17.67% annualized return and META not far behind at 17.39%.
UTHR
- 1D
- 0.10%
- 1M
- -3.98%
- YTD
- 12.05%
- 6M
- 10.52%
- 1Y
- 92.68%
- 3Y*
- 33.49%
- 5Y*
- 24.97%
- 10Y*
- 17.67%
META
- 1D
- -0.26%
- 1M
- -7.69%
- YTD
- -14.03%
- 6M
- -11.84%
- 1Y
- -16.71%
- 3Y*
- 28.18%
- 5Y*
- 11.52%
- 10Y*
- 17.39%
UTHR vs. META - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 12.05% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
META Meta Platforms, Inc. | -14.03% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 56.57% | -25.71% | 53.38% |
Correlation
The correlation between UTHR and META is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since May 18, 2012 | 0.19 |
The correlation between UTHR and META shifts across timeframes, from 0.07 (1 year) to 0.19 (all time), reflecting how their relationship changes across market environments.
Fundamentals
UTHR:
$25.77B
META:
$1.45T
UTHR:
$27.00
META:
$27.47
UTHR:
20.22
META:
20.64
UTHR:
0.66
META:
0.85
UTHR:
8.21
META:
6.78
UTHR:
4.37
META:
5.97
UTHR:
$3.17B
META:
$214.96B
UTHR:
$2.74B
META:
$176.14B
UTHR:
$1.75B
META:
$106.31B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. META — Risk / Return Rank
UTHR
META
UTHR vs. META - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UTHR | META | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.43 | ||
| Sortino ratioReturn per unit of downside risk | +4.78 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 0.93 | +0.56 |
| Calmar ratioReturn relative to maximum drawdown | 8.58 | -0.54 | +9.12 |
| Martin ratioReturn relative to average drawdown | 20.13 | -1.12 | +21.25 |
Loading charts...
Drawdowns
UTHR vs. META - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for UTHR and META.
Loading charts...
Drawdown Indicators
| UTHR | META | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -76.74% | -16.44% |
Max Drawdown (1Y)Largest decline over 1 year | -10.64% | -33.30% | +22.66% |
Max Drawdown (3Y)Largest decline over 3 years | -33.00% | -34.15% | +1.15% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -76.74% | +43.74% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | -76.74% | +21.18% |
Current DrawdownCurrent decline from peak | -8.51% | -28.06% | +19.55% |
Average DrawdownAverage peak-to-trough decline | -35.31% | -15.83% | -19.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 16.06% | -11.53% |
Volatility
UTHR vs. META - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 5.01%, while Meta Platforms, Inc. (META) has a volatility of 10.17%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTHR | META | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.01% | 10.17% | -5.16% |
Volatility (6M)Calculated over the trailing 6-month period | 25.94% | 26.91% | -0.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.55% | 35.52% | +12.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.08% | 44.04% | -8.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.06% | 38.67% | -3.61% |
Dividends
UTHR vs. META - Dividend Comparison
UTHR has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.37%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
META Meta Platforms, Inc. | 0.37% | 0.32% | 0.34% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% |
Financials
UTHR vs. META - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. META - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.
Frequently Asked Questions
UTHR and META have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
META has higher volatility (10.17%) compared to UTHR (5.01%). In terms of maximum drawdown, UTHR dropped -93.18% vs META's -76.74%.
UTHR currently has the higher Sharpe Ratio (1.92 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTHR and META
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer